# Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/perioperative-dose-dense-methotrexate-vinblastine-doxorubicin-and-cisplatin-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christian Pfister,Gwénaëlle Gravis,Aude Fléchon,Christine Chevreau,Hakim Mahammedi,Brigitte Laguerre,Aline Guillot,Florence Joly,M. Soulié,Yves Allory,Valentin Harter,Stéphane Culine,G. Pignot,J.P. Fendler,Laurent Guy,G. Verhoest,Nicolas Mottet,A. Doerfler,Sophie Abadie Lacourtoisie,A.R. Azzouzi,P. Mongiat,Lionnel Geoffrois,Pascal Eschwège,Frédéric Di Fiore,Guilhem Roubaud,J.L. Hoepffner,Philippe Barthélémy,Hervé Lang,Éric Voog,E. Mandron,Jean Marc Tourani,Camille Serrate,A. Colau,Carolina Saldana,Alexandre de la Taille,Thi Hong Lieu Nguyen,F. Kleinclauss,Yohan LORIOT,Jacques Irani,J.C. Eymard,S. Larré,Olivier Huillard,Marc Zerbib,Frédéric Rolland,J. Rigaud,Nadine Houédé,S. Droupy,Georgina MALOUF,Morgan Rouprêt,S. Vieillot,N. Letang,T. L'Haridon,N. Gaschignard,Werner Hilgers,Jean Louis DAVIN |
| Citations | 106 |
| DOI | 10.1016/s1470-2045(23)00587-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4390065870 |
| PMID | 38142702 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Nicolas Mottet](https://scholariq.org/researchers/nicolas-mottet/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Paper topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.